China reported a sharp uptick in coronavirus cases; a Massachusetts lawsuit claims Juul advertisements targeted children; motion picture technology is being used in rehab centers.
A record rise in deaths and thousands more cases of coronavirus were reported in the Chinese province of Hubei, Reuters reports. The uptickmay be the result of a newly implemented diagnostic method. On February 12, Hubei health officials reported 242 deaths in 1 day, marking the fastest rise in daily count since the outbreak began. Previously, RNA tests were used to confirm cases, but now computerized tomography scans are being used in Hubei to more quickly reveal lung infections. Meanwhile, the CDC confirmed a second case of the virus in San Diego, The Los Angeles Times reports.
A lawsuit filed on February 12 by the Massachusetts attorney general’s office found Juul Labs Inc bought online advertisements featured on Nickelodeon, Cartoon Network, and Seventeen magazine websites, Reuters reports. The company previously denied it ever intentionally targeted teenagers. The lawsuit claims the company worked through online ad buyers to purchase slots on websites utilized by children and teens between 2015 and 2016. Educational websites like coolmath-games.com and socialstudiesforkids.com also listed Juul advertisements.
Technology used in Hollywood to capture actors’ movements is being used by hospitals and rehab centers to analyze patients with mobility-limiting conditions like Parkinson disease, STAT reports. Data are collected by reflective markers tracked by infrared cameras when actors move on screen. The same data collected from the cameras are used by physical therapists to make treatment recommendations. The technology can also be used for those recovering from stroke-induced paralysis and other muscular conditions.
Major Study Expands in Hopes to Cure Parkinson Disease
April 19th 2022April is Parkinson’s Disease Awareness month, and on this episode of Managed Care Cast, we take a look at the Parkinson's Progression Markers Initiative (PPMI), a study from the Michael J. Fox Foundation for Parkinson's Research (MJFF). The multicenter, international study aims to end Parkinson disease, which is expected to double worldwide by 2040, to more than 14 million people.
Listen
Certain Patient Groups Continue to Be Underrepresented in PD Studies in the Netherlands
February 4th 2023With greater attention being paid to the heterogenous patient population, researchers questioned whether this has resulted in a more diverse group of patients included in Parkinson disease (PD) studies in the Netherlands.
Read More
An Inside Look at Innovations by MJFF to Assist the Parkinson Community Amid the COVID-19 Pandemic
May 26th 2020On this episode of Managed Care Cast, we speak with Rachel Dolhun, MD, vice president of Medical Communications at The Michael J. Fox Foundation for Parkinson Research, about recent innovations by The Michael J. Fox Foundation to assist patients and families of patients with Parkinson disease in adjusting to this new normal.
Listen
Motor Symptoms May Occur 3 Years Before Parkinson Disease Diagnosis, Study Says
January 20th 2023Trouble with balance and holding objects above one's head were just a few of the problems reported by patients 3 years before they received a formal Parkinson disease diagnosis, according to a recent study.
Read More
Major Study Expands in Hopes to Cure Parkinson Disease
April 19th 2022April is Parkinson’s Disease Awareness month, and on this episode of Managed Care Cast, we take a look at the Parkinson's Progression Markers Initiative (PPMI), a study from the Michael J. Fox Foundation for Parkinson's Research (MJFF). The multicenter, international study aims to end Parkinson disease, which is expected to double worldwide by 2040, to more than 14 million people.
Listen
Certain Patient Groups Continue to Be Underrepresented in PD Studies in the Netherlands
February 4th 2023With greater attention being paid to the heterogenous patient population, researchers questioned whether this has resulted in a more diverse group of patients included in Parkinson disease (PD) studies in the Netherlands.
Read More
An Inside Look at Innovations by MJFF to Assist the Parkinson Community Amid the COVID-19 Pandemic
May 26th 2020On this episode of Managed Care Cast, we speak with Rachel Dolhun, MD, vice president of Medical Communications at The Michael J. Fox Foundation for Parkinson Research, about recent innovations by The Michael J. Fox Foundation to assist patients and families of patients with Parkinson disease in adjusting to this new normal.
Listen
Motor Symptoms May Occur 3 Years Before Parkinson Disease Diagnosis, Study Says
January 20th 2023Trouble with balance and holding objects above one's head were just a few of the problems reported by patients 3 years before they received a formal Parkinson disease diagnosis, according to a recent study.
Read More
2 Commerce Drive
Cranbury, NJ 08512